Lysophosphatidylserine Stimulates Chemotactic Migration of Colorectal Cancer Cells Through GPR34 and PI3K/Akt Pathway

被引:1
|
作者
Iida, Yuuki [1 ]
Tsuno, Nelson H. [2 ]
Kishikawa, Junko [1 ]
Kaneko, Kensuke [1 ]
Murono, Koji [1 ]
Kawai, Kazushige [1 ]
Ikeda, Toshiyuki [2 ]
Ishihara, Soichiro [1 ]
Yamaguchi, Hironori [1 ]
Sunami, Eiji [1 ]
Kitayama, Joji [1 ]
Yatomi, Yutaka [3 ]
Watanabe, Toshiaki [1 ]
机构
[1] Univ Tokyo, Fac Med Sci, Dept Surg Oncol, Tokyo 1138655, Japan
[2] Univ Tokyo, Fac Med Sci, Dept Transfus Med, Tokyo 1138655, Japan
[3] Univ Tokyo, Fac Med Sci, Dept Clin Lab Med, Tokyo 1138655, Japan
关键词
Lysophosphatidylserine; GPR34; colorectal cancer; chemotactic migration; BINDS ANIONIC PHOSPHOLIPIDS; TUMOR BLOOD-VESSELS; MONOCLONAL-ANTIBODY; AUTOTAXIN; ROLES; MICE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lysophosphatidylserine (lysoPS) is a type of lysophospholipid mediator, which is involved in allergic conditions and tumor progression. We investigated the physiological function of lysoPS on colorectal cancer (CRC) cell lines, as well as the involved receptor and signaling pathways. Materials and Methods: Expression of lysoPS receptors on six cell lines was examined by reverse transcription-polymerase chain reaction (RT-PCR). The physiological functions of lysoPS were investigated, and experiments using small interfering RNA (siRNA) or inhibitors of the signaling pathways were conducted. Results: Among the three lysoPS receptors, GPR34 was highly expressed on all cell lines. LysoPS stimulated the chemotactic migratory ability. Wortmannin inhibited the migratory ability, as well as the GPR34 knock-down, strongly suggestive of the involvement of this receptor in the PI3K/Akt pathway. Conclusion: The involved receptor and pathways in the migratory ability in response to lysoPS was demonstrated, which opens premises for targeting as a new strategy for prevention and treatment of colorectal cancer.
引用
收藏
页码:5465 / 5472
页数:8
相关论文
共 50 条
  • [41] Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway
    Hou, Bin
    Li, Wenhan
    Li, Jianhui
    Ma, Jia
    Xia, Peng
    Liu, Zhao
    Zeng, Qingnuo
    Zhang, Xin
    Chang, Dongmin
    ONCOLOGY REPORTS, 2020, 43 (02) : 536 - 548
  • [42] Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway
    Tan, Xinyue
    Gong, Liuyun
    Li, Xinyue
    Zhang, Xinyue
    Sun, Jiahao
    Luo, Xuehui
    Wang, Qi
    Chen, Jie
    Xie, Lina
    Han, Suxia
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 143
  • [43] Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway
    Zhang, Pei
    Zhao, Surong
    Lu, Xingyue
    Shi, Zongfen
    Liu, Hao
    Zhu, Bing
    GENE, 2020, 745
  • [44] Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells
    Amable, Gaston
    Martinez-Leon, Eduardo
    Elisa Picco, Maria
    Di Siervi, Nicolas
    Davio, Carlos
    Rozengurt, Enrique
    Rey, Osvaldo
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2019, 112 : 88 - 94
  • [45] Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells
    Tian, Tao
    Sun, Jinpeng
    Wang, Jianxin
    Liu, Yanchun
    Liu, Haitao
    ONCOLOGY LETTERS, 2018, 16 (05) : 6133 - 6139
  • [46] Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway
    Dong, Weihua
    Wang, Fang
    Liu, Qingyu
    Wang, Tianyun
    Yang, Yun
    Guo, Peixia
    Li, Xiang
    Wei, Bingdi
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2022, 17 (02) : 178 - 186
  • [47] Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway
    Qiang, P.
    Shao, Y.
    Sun, Y-P
    Zhang, J.
    Chen, L-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1778 - 1785
  • [48] The PI3K/AKT Pathway as a Target for Cancer Treatment
    Mayer, Ingrid A.
    Arteaga, Carlos L.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 11 - 28
  • [49] The PI3K/AKT pathway in the pathogenesis of prostate cancer
    Chen, Huixing
    Zhou, Lan
    Wu, Xiaorong
    Li, Rongbing
    Wen, Jiling
    Sha, Jianjun
    Wen, Xiaofei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1084 - 1091
  • [50] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
    Li, Na
    Yang, Fan
    Liu, Dong-Yan
    Guo, Jin-Tao
    Ge, Nan
    Sun, Si-Yu
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (09) : 1164 - 1183